Author: Emma Yasinski

Emma Yasinski

I am a freelance science and medical journalist, fascinated by how the scientific process leads to incredible discoveries, but also can lead to publication bias leaning toward positive findings and minimizing negatives. With a bachelor’s degree in neuroscience from Lafayette College and a Master’s in Science and Medical Journalism from Boston University, I’ve written about clinical trial transparency, organ donation, and basic molecular biology for publications like The Scientist, The Atlantic,, Kaiser Health News, and more. At MedShadow, I research and write about the sometimes unexpected ways that medicines can affect us, and what we can do if and when it does.

In the last week of September 2021, a group of more than 90 doctors and researchers published a call to action, cautioning against the liberal use of Tylenol (acetaminophen) during pregnancy. The studies suggested that exposure to the drug could increase the risk of a baby having neurodevelopmental, reproductive and urogenital disorders. The authors added, however, that Tylenol has long been considered one of the few safer options to treat pain in pregnancy, since Advil (ibuprofen) and opioids are considered riskier. They pointed out that, in some cases, a woman’s condition (fever and pain, for example) could be worse for…

Read More

Anxiety is a normal reaction to stress, but for some people, it can become overwhelming and debilitating. People with types of anxiety disorder feel apprehensive and uneasy, and it’s common for them to experience negative thoughts that make them more fearful. According to the National Institute of Mental Health (NIMH): More than 40 million American adults ages 18 and older have an anxiety disorder, and nearly one-third of adults will experience an anxiety disorder at some point in their life. Anxiety disorders frequently co-occur with depressive disorders or substance abuse. Most people with an anxiety disorder also have depression.  Most…

Read More